T0	RNA-Noncoding 179 188	LINC00667
T10	RNA-Noncoding 615 624	LINC00667
T12	RNA-Noncoding 683 692	LINC00667
T13	Disease 742 747	NSCLC
T14	RNA-Noncoding 876 885	LINC00667
T15	Disease 964 969	NSCLC
T16	RNA-Noncoding 1023 1032	LINC00667
T17	Disease 1178 1183	tumor
#8	AnnotatorNotes T17	DOID:162
T18	RNA-Noncoding 1219 1228	LINC00667
T2	RNA-Noncoding 246 255	LINC00667
T4	Disease 314 338	hepatocellular carcinoma
#12	AnnotatorNotes T4	DOID:684
T5	Disease 368 373	NSCLC
#13	AnnotatorNotes T5	DOID:3908
T6	RNA-Noncoding 457 466	LINC00667
T8	Disease 491 497	cancer
#15	AnnotatorNotes T8	DOID:14566|DOID:162
T9	Disease 510 515	NSCLC
#1	AnnotatorNotes T0	HGNC:27906
T1	RNA-Noncoding 234 244	miR-143-3p
#2	AnnotatorNotes T1	HGNC:31530
T3	RNA-Noncoding 1046 1056	miR-143-3p
T7	RNA-Noncoding 629 639	miR-143-3p
T11	RNA-Noncoding 890 900	miR-143-3p
T19	RNA-Noncoding 697 707	miR-143-3p
T21	Biomarker 246 255	LINC00667
R1	Association Arg1:T21 Arg2:T4	
T22	Biomarker 457 487	LINC00667 was highly expressed
T23	Collection 491 515	cancer tissues and NSCLC
R2	Association Arg1:T22 Arg2:T23	
T24	Biomarker 615 624	LINC00667
T25	Biomarker 629 639	miR-143-3p
T26	Biomarker 669 707	expression of LINC00667 and miR-143-3p
T28	Gene-Protein 849 853	RRM2
#3	AnnotatorNotes T28	HGNC:10452
T29	Biomarker 849 941	RRM2 was regulated by both LINC00667 and miR-143-3p, and all three molecules synergistically
R3	Association Arg1:T29 Arg2:T15	
T30	Gene-Protein 1105 1109	RRM2
T31	Drug 1023 1042	LINC00667 knockdown
#4	AnnotatorNotes T31	not found
T32	Drug 1046 1071	miR-143-3p overexpression
#5	AnnotatorNotes T32	not found
T33	Collection 1023 1071	LINC00667 knockdown or miR-143-3p overexpression
R4	Response Arg1:T33 Arg2:T17	
T34	Biomarker 1219 1228	LINC00667
R5	Association Arg1:T34 Arg2:T15	
